Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on the day's biggest business stories
Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Facing a brutal new wave of coronavirus cases, India on Thursday made anyone over 45 eligible for vaccination. But the scramble to vaccinate as many people as possible has also meant sharply curtailing exports.
Why it matters: The hopes of vaccinating the world have largely fallen on the shoulders of India, a vaccine manufacturing powerhouse and home to the world’s largest producer, the Serum Institute.
- Until recently, India was exporting most of the doses it was producing — a mix of donations to neighbors and other friendly nations, sales to countries like Saudi Arabia and the U.K., and contributions to the global COVAX initiative.
- Indian-made vaccines have gone to 82 countries.
- Then, after a long lull, cases began to surge. They are now at their highest point since mid-October and are continuing to climb precipitously.
- Vaccine exports, which had been ramping up, suddenly fell sharply. Rather than supplying the world, the Serum Institute appears to have redirected nearly its entire supply to the homefront.
Driving the news: India has not imposed an export ban and will continue to supply doses, including to COVAX, a government source tells Axios. But given "domestic requirements," the source added, "there is some recalibration of the supply schedules.”
- Another official, speaking to Reuters, put it more bluntly: “Right now we are dealing with an emergency situation. Whatever we have, we will use it,” the official said.
- The government aims to vaccinate a minimum of 400 million people, up from 56 million at present (just 4% of the population), the official told Reuters.
By the numbers: India has exported 6 million doses over the last three weeks, with less than 2 million of those going to the COVAX initiative.
- That’s down from 31 million in the three prior weeks, of which 16 million went to COVAX
That’s a crippling setback for COVAX, which is a critical source of vaccines for low-income countries, particularly in Africa.
- COVAX had expected 71% of its first wave of distribution to consist of AstraZeneca doses produced at the Serum Institute, according to a preliminary forecast.
- A spokesman for Gavi, the vaccine alliance, said shipments expected in March and April had been delayed, and COVAX is now “in talks with the government of India in the hope of ensuring some supplies are completed during April.”
What to watch: If this is anything more than a temporary delay, “that would be catastrophic,” African CDC director John Nkengasong told reporters Thursday. He said Africa would likely fall short of its vaccination targets this year.
The big picture: The world currently has four major sources of vaccines. The U.S. is the second-largest producer, just ahead of India, but isn't exporting at all.
- China is currently the top producer and top exporter, according to Airfinity, focusing less on the domestic rollout in part because the virus remains under control in the country.
- The EU, meanwhile, has exported around 40% of its supply to date, but it's in the midst of a vigorous debate about whether and how to curb exports.